Thursday, December 6, 2012
Tranzyme Pharma’s CFO to Step Down
The vice president of finance and chief financial officer for the biopharmaceutical company Tranzyme Pharma, Richard Eisenstadt, announced Wednesday he has resigned effective Jan. 4.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment